SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 201.28-2.1%Nov 13 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: squetch who wrote (15095)2/14/1998 7:02:00 PM
From: Henry Niman  Read Replies (2) of 32384
 
Stan, Speaking of LGND's drug, Targretin, the four analysts that cover LGND (Bear Stearns, Robertson Stephens, Lehman Brothers, and Hambrecht & Quist) all expect an NDA filing on oral Targretin this year (or early next year at the latest). Most investors would consider such a time frame as "soon". I guess day traders measure time in seconds, so the end of this year seems to them to be a looong way to market.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext